Myomo (MYO) Net Margin (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,169.00 |
| Jun 30, 2025 | -1,275.00 |
| Mar 31, 2025 | -8,964.00 |
| Dec 31, 2024 | 6,489.00 |
| Sep 30, 2024 | 442.00 |
| Jun 30, 2024 | 8,725.00 |
| Mar 31, 2024 | -23,371.00 |
| Dec 31, 2023 | 17,149.00 |
| Sep 30, 2023 | -2,292.00 |
| Jun 30, 2023 | 5,970.00 |
| Mar 31, 2023 | -1,862.00 |
| Dec 31, 2022 | 1,321.00 |
| Sep 30, 2022 | 779.00 |
| Jun 30, 2022 | -632.00 |
| Mar 31, 2022 | 1,089.00 |
| Dec 31, 2021 | -3,675.00 |
| Sep 30, 2021 | 3,752.00 |
| Jun 30, 2021 | 4,228.00 |
| Mar 31, 2021 | -8,191.00 |
| Dec 31, 2020 | 9,930.00 |
| Sep 30, 2020 | 23,872.00 |
| Jun 30, 2020 | 6,082.00 |
| Mar 31, 2020 | -26,205.00 |
| Dec 31, 2019 | 27,802.00 |
| Sep 30, 2019 | -16,822.00 |
| Jun 30, 2019 | 11,769.00 |
| Mar 31, 2019 | -10,648.00 |
| Dec 31, 2018 | 13,251.00 |
| Sep 30, 2018 | -1,930.00 |
| Jun 30, 2018 | 33,307.00 |
| Mar 31, 2018 | 169,865.00 |
| Dec 31, 2017 | -218,985.00 |
| Sep 30, 2017 | 227,084.00 |
| Jun 30, 2017 | 690,638.00 |
| Mar 31, 2017 | -912,160.00 |
| Dec 31, 2016 | 34,410.00 |
| Sep 30, 2016 | -28,321.00 |